ROMANO KATHRYN sold KRYS
February 9, 2026 · Form 4 insider transaction
ROMANO KATHRYN sold 2,824 shares of Krystal Biotech, Inc. at $272.51 per share, a transaction worth $769.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,824
Price
$272.51
Total value
$769.6K
InsiderROMANO KATHRYN
Role—
CompanyKrystal Biotech, Inc. (KRYS)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after21,294
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction was executed in multiple trades ranging from $272.1275 to $273.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.